Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

α-Demethylnaproxen

Copy Product Info
😃Good
Catalog No. T7662Cas No. 23981-47-7

α-Demethylnaproxen is a competitive inhibitor of COX(Ki values of 21 and 19 μM for ovine COX-1 and -2, respectively)

α-Demethylnaproxen

α-Demethylnaproxen

Copy Product Info
😃Good
Purity: 97.57%
Catalog No. T7662Cas No. 23981-47-7
α-Demethylnaproxen is a competitive inhibitor of COX(Ki values of 21 and 19 μM for ovine COX-1 and -2, respectively)
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$30In StockIn Stock
50 mg$41In StockIn Stock
100 mg$68-In Stock
200 mg$100-In Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.57%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

α-Demethylnaproxen AI Summary
α-Demethylnaproxen exhibits a range of bioactivities across various assays and biological systems. It inhibits the proliferation of HMVEC-L cells in vitro with a 5.0% inhibition of [3H]thymidine incorporation. The compound shows inhibitory activity against ovine cyclooxygenase-1 (COX-1) at 200 uM but is considered inactive in this assay as the inhibition was less than 50.0%. Notably, α-Demethylnaproxen inhibits Leukotriene LTC4 Synthase with an IC50 of 49660.0 nM and COX-1 with an IC50 of 4113.0 nM. Additionally, it inhibits mouse COX2-mediated 2-arachidonoylglycerol oxygenation with an IC50 of 1400.0 nM and arachidonic acid oxygenation at 10 uM with a 16.0% inhibition rate. It impacts various physiological markers, affecting liver and kidney function, metabolism, blood cell counts, electrolyte balance, and lipid levels. Furthermore, α-Demethylnaproxen inhibits human recombinant AKR1C3 with an IC50 of 650.0 nM, showing a higher selectivity for this enzyme over AKR1C2, which it inhibits with an IC50 of 19040.0 nM, resulting in a selectivity ratio of 29.0 for AKR1C2 to AKR1C3..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
α-Demethylnaproxen is a competitive inhibitor of COX(Ki values of 21 and 19 μM for ovine COX-1 and -2, respectively)
Targets&IC50
COX-1:21 Μm(ki), COX-2:19 μM(ki)
Chemical Properties
Molecular Weight216.23
FormulaC13H12O3
Cas No.23981-47-7
SmilesCOc1ccc2cc(CC(O)=O)ccc2c1
Relative Density.1.235 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 3.6 mg/mL (16.65 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM4.6247 mL23.1235 mL46.2471 mL231.2353 mL
5 mM0.9249 mL4.6247 mL9.2494 mL46.2471 mL
10 mM0.4625 mL2.3124 mL4.6247 mL23.1235 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy α-Demethylnaproxen | purchase α-Demethylnaproxen | α-Demethylnaproxen cost | order α-Demethylnaproxen | α-Demethylnaproxen chemical structure | α-Demethylnaproxen formula | α-Demethylnaproxen molecular weight